Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

190 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Correction: Certolizumab Pegol for the Treatment of Plaque Psoriasis in Routine Clinical Practice: One-Year Results from the CIMREAL Study.
Korge B, Vanhooteghem O, Lynde CW, Machovcova A, Perrussel M, Lazaridou E, Marasca C, Sarro DV, Pousa ID, Fierens F, Williams P, Shimizu S, Heidbrede T, Warren RB. Korge B, et al. Among authors: lazaridou e. Dermatol Ther (Heidelb). 2024 Oct;14(10):2923-2926. doi: 10.1007/s13555-024-01271-4. Dermatol Ther (Heidelb). 2024. PMID: 39340697 Free PMC article. No abstract available.
Certolizumab Pegol for the Treatment of Plaque Psoriasis in Routine Clinical Practice: One-Year Results from the CIMREAL Study.
Korge B, Vanhooteghem O, Lynde CW, Machovcova A, Perrussel M, Lazaridou E, Marasca C, Sarro DV, Pousa ID, Fierens F, Williams P, Shimizu S, Heidbrede T, Warren RB. Korge B, et al. Among authors: lazaridou e. Dermatol Ther (Heidelb). 2024 Aug;14(8):2077-2092. doi: 10.1007/s13555-024-01210-3. Epub 2024 Jun 27. Dermatol Ther (Heidelb). 2024. PMID: 38937404 Free PMC article.
Sub-population analysis of patients with plaque psoriasis treated with calcipotriol/betamethasone aerosol foam; effectiveness and patient satisfaction, according to baseline disease severity and prior psoriasis treatment experience, in a Greek population.
Rigopoulos D, Lazaridou E, Papadavid E, Georgiou S, Chasapi V, Sfaelos K, Cheliotis G, Ioannides D. Rigopoulos D, et al. Among authors: lazaridou e. Dermatol Ther. 2022 Jun;35(6):e15484. doi: 10.1111/dth.15484. Epub 2022 May 9. Dermatol Ther. 2022. PMID: 35373423
Real-world data on the effectiveness of brodalumab in patients with moderate-to severe plaque psoriasis in the Greek clinical setting (the BrIDGE study).
Rigopoulos D, Tampouratzi E, Angelakopoulos C, Apalla Z, Barkis I, Georgiou S, Delli F, Drosos A, Zafiriou E, Katsantonis J, Lazaridou E, Panagakis P, Papadavid E, Papakonstantis M, Roussaki-Schulze AV, Sotiriou E, Anastasiadis G, Chasapi V, Sfaelos K, Ioannides D; BrIDGE Study Group. Rigopoulos D, et al. Among authors: lazaridou e. J Eur Acad Dermatol Venereol. 2024 Jun;38(6):1121-1130. doi: 10.1111/jdv.19816. Epub 2024 Feb 3. J Eur Acad Dermatol Venereol. 2024. PMID: 38308561
Real world experience of brodalumab treatment in patients with moderate-to-severe plaque psoriasis in the Greek population: Results from an interim analysis of the BrIDGE study.
Rigopoulos D, Angelakopoulos C, Apalla Z, Georgiou S, Delli F, Drosos A, Zafiriou E, Katsantonis J, Lazaridou E, Panagakis P, Papadavid E, Papakonstantis M, Roussaki-Schulze AV, Sotiriou E, Anastasiadis G, Tampouratzi E, Chasapi V, Sfaelos K, Ioannides D; BrIDGE Study Group. Rigopoulos D, et al. Among authors: lazaridou e. Dermatol Ther. 2022 Dec;35(12):e15886. doi: 10.1111/dth.15886. Epub 2022 Nov 1. Dermatol Ther. 2022. PMID: 36184757
Patch Testing in Patients With Alopecia Areata: A Case-series Study.
Kyrmanidou E, Sotiriou E, Ioannides D, Apalla Z, Emvalomati A, Lazaridou E. Kyrmanidou E, et al. Among authors: lazaridou e. Dermatol Pract Concept. 2022 Oct 1;12(4):e2022199. doi: 10.5826/dpc.1204a199. eCollection 2022 Nov. Dermatol Pract Concept. 2022. PMID: 36534550 Free PMC article. No abstract available.
Real-world clinical outcomes of treatment with brodalumab in patients with moderate-to-severe psoriasis: a retrospective, 24-month experience from four academic dermatology centers in Greece.
Papadavid E, Zafeiriou E, Georgiou S, Roussaki-Schulze AV, Spiliopoulos T, Vryzaki E, Oikonomou C, Drongoula O, Boziou M, Goudouras G, Sfaelos K, Apalla Z, Lazaridou E. Papadavid E, et al. Among authors: lazaridou e. J Dermatolog Treat. 2022 Nov;33(7):3053-3059. doi: 10.1080/09546634.2022.2110836. Epub 2022 Aug 23. J Dermatolog Treat. 2022. PMID: 36000186 Free article.
The journey of patients with skin diseases from the first consultation to the diagnosis in a representative sample of the European general population from the EADV burden of skin diseases study.
Richard MA, Paul C, Nijsten T, Gisondi P, Salavastru C, Taieb C, Stratigos A, Trakatelli M, Puig L; EADV Burden of Skin Diseases Project Team. Richard MA, et al. J Eur Acad Dermatol Venereol. 2023 Oct;37 Suppl 7:17-24. doi: 10.1111/jdv.18916. J Eur Acad Dermatol Venereol. 2023. PMID: 37806003
190 results